Clinical report reveals upper airway stimulation for obstructive sleep apnoea in Asian patients, highlighting alternatives amid low continuous positive airway pressure adherence.
Obstructive sleep apnoea (OSA) is the most prevalent sleep-related breathing disorder, affecting approximately 15% of the global population.1 In Singapore, 30.5% of the population has moderate-to-severe OSA.2 The gold standard treatment, continuous positive airway pressure (CPAP) therapy, often has poor adherence, with only 13.8% of Singaporeans diagnosed with OSA adhering to CPAP therapy after 1 year.3
No takes yet. Share an insight, caveat, or question.
Loh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: